CATO HOLDING CO Insider Profile
4 Followers
CATO HOLDING CO, Ten Percent Owner at VistaGen Therapeutics, holds 3.31M shares in VistaGen Therapeutics (Ticker: VTGN), holds 3.86M shares in Echo Therapeutics (Ticker: ECTE). Most recently, CATO HOLDING CO Bought ― shares of VistaGen Therapeutics on Dec 16, 2011 for an estimated value of $471.73K.
CATO HOLDING CO's Trading History
| VTGNVistaGen Therapeutics | Dec 16, 2011 | Ten Percent Owner | Informative Buy | 471.73K | $595.95K | |
| ECTEEcho Therapeutics | ― | ― | ― | $115.66K |
You May Also Like
CATO HOLDING CO insider profile FAQ
What is the percentage of profitable transactions made by CATO HOLDING CO?
The percentage of profitable transactions made by CATO HOLDING CO is 0%.
What is the average return per transaction made by CATO HOLDING CO?
The average return per transaction made by CATO HOLDING CO is -77.30%.
What stocks does CATO HOLDING CO hold?
CATO HOLDING CO holds: VTGN, ECTE stocks.
What was CATO HOLDING CO’s latest transaction?
CATO HOLDING CO’s latest transaction was an Informative Buy of $471.73K.
What was CATO HOLDING CO's most profitable transaction?
CATO HOLDING CO’s most profitable transaction was an Informative Buy of VTGN stock on December 16, 2011. The return on the trade was -74.80%.
What is CATO HOLDING CO's role in VistaGen Therapeutics?
CATO HOLDING CO's role in VistaGen Therapeutics is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
